Alvotech News

Alvotech S.A. Annual General Meeting to Be Held June 7, 2024

The Annual General Meeting of Alvotech S.A. will be held on Friday June 7, 2024, at 09.00 a.m. CEST at the premises of Arendt & Medernach S.A. at 41A, Avenue John F. Kennedy L-1855 Luxembourg, Grand D

GlobeNewswireMay 15 21:30

Private Equity Firms Are Alvotech's (NASDAQ:ALVO) Biggest Owners and Were Hit After Market Cap Dropped US$179m

Key Insights The considerable ownership by private equity firms in Alvotech indicates that they collectively have a greater say in management and business strategy A total of 2 investors have a majo

Simply Wall StMay 8 21:26

Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals

Alvotech (ALVO) and Teva Pharmaceuticals' (TEVA) US affiliate said Tuesday that Alvotech will manufacture a high-concentration interchangeable biosimilar to Humira for Quallent Pharmaceuticals, which

MT NewswiresApr 30 23:32

Alvotech To Manufacture Its High-concentration Interchangeable Biosimilar To Humira For Quallent

RTTNewsApr 30 17:18

AbbVie Stock Slides 6% Amid Concerns About Falling Humira Sales

Seeking AlphaApr 27 02:09

Alvotech's Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study

Alvotech (ALVO.IC) on Wednesday said the confirmatory clinical trial for its Simponi and Simponi Aria biosimilar candidate AVT05 showed positive results in treating patients with moderate to severe rh

MT NewswiresApr 24 20:07

Alvotech Announced Positive Topline Results From A Confirmatory Clinical Study For AVT05, Alvotech's Proposed Biosimilar To Simponi And Simponi Aria (Golimumab)

Alvotech Announced Positive Topline Results From A Confirmatory Clinical Study For AVT05, Alvotech's Proposed Biosimilar To Simponi And Simponi Aria (Golimumab)

BenzingaApr 24 16:02

Analysts Are Bullish on These Healthcare Stocks: Alvotech (ALVO), Cardinal Health (CAH)

TipRanksApr 23 18:07

Sector Update: Health Care Stocks Advance Late Afternoon

Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index rising 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%. The iShares Biotechnology ETF (IBB) dec

MT NewswiresApr 20 04:00

Alvotech Shares Are Trading Higher Today After the Company Signed an Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in the US.

Alvotech Shares Are Trading Higher Today After the Company Signed an Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in the US.

BenzingaApr 19 22:57

Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Nasdaq Composite falling over 100 points on Friday.Shares of Fifth Third Bancorp (NASDAQ:FITB) rose during Friday's session after the company reported better-than-expe

BenzingaApr 19 22:40

Alvotech, Teva Signs Deal to Expand Access for Humira Biosimilar in U.S.

Seeking AlphaApr 19 18:55

Alvotech Inks Long-Term Agreement With A Strategic Partner To Further Enhance Access To Adalimumab-ryvk In US Market

"This new partnership agreement supports our financial guidance and reflects Alvotech's strong commitment to increasing patient access to more affordable healthcare," said Robert Wessman, Chairman and

BenzingaApr 19 18:11

CVS Favors Humira Copycats Hurting AbbVie's Market Share: Evercore

Seeking AlphaApr 17 21:26

Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), Alvotech (ALVO) and Pacific Biosciences (PACB)

TipRanksApr 17 15:30

Alvotech And Teva : FDA Approves Selarsdi Injection For Psoriasis And Psoriatic Arthritis

RTTNewsApr 17 11:10

FDA Approves Alvotech Biosimilar of J&J Top-selling Drug Stelara

Seeking AlphaApr 17 06:22

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI (Ustekinumab-aekn), Biosimilar to Stelara (Ustekinumab)

Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara.

GlobeNewswireApr 17 05:30

Alvotech Receives FDA Approval For Selarsdi For Moderate To Severe Plaque Psoriasis

Alvotech receives FDA approval for Selarsdi for moderate to severe plaque psoriasisAdult patients with:moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy

BenzingaApr 17 03:46

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 14:37